Novavax, Inc. (FRA:NVV1)
7.44
-0.50 (-6.24%)
At close: Jan 30, 2026
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
€953,153
Profits / Employee
€305,955
Market Cap
1.21B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Bayer Aktiengesellschaft | 88,502 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 62,346 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,041 |
| Gerresheimer AG | 13,535 |
| SCHOTT Pharma AG & Co. KGaA | 4,811 |
| Evotec SE | 4,788 |
Novavax News
- 11 days ago - Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M - Seeking Alpha
- 11 days ago - Novavax Shares Rise After Licensing Deal With Pfizer - Benzinga
- 12 days ago - Novavax (NVAX) Surges on Licensing Deal with Pfizer - GuruFocus
- 12 days ago - Novavax rises after licensing deal with Pfizer - Seeking Alpha
- 12 days ago - Novavax Licenses Matrix-M Adjuvant To Pfizer For Upfront Payment Of $30 Mln - Nasdaq
- 12 days ago - Novavax Announces Entering into a License Agreement with Pfizer - PRNewsWire
- 12 days ago - Novavax enters license agreement with Pfizer for vaccine development - Reuters
- 15 days ago - Notable Friday Option Activity: BLSH, HIMS, NVAX - Nasdaq